Neuropharmacology

Neuropharmacology is published by Elsevier Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroscience and Neuropharmacology Research, Neurotransmitter Receptor Influence on Behavior and Receptor Mechanisms and Signaling, together about 44.8% of its articles. Its main subfields are Cellular and Molecular Neuroscience and Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)

Neuropharmacology publishes high quality, original research within the discipline of neuroscience. The emphasis of Neuropharmacology is on the study and understanding of the actions of known exogenous and endogenous chemical agents on neurobiological processes in the mammalian nervous system. Work with non-mammalian and invertebrate species may be considered in exceptional circumstances. The journal does not usually accept clinical research, although neuropharmacological studies in humans may be considered on the condition that they provide novel insight into either the actions of drugs and/or neurobiological mechanisms. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Similarly, manuscripts describing the use of natural products will only be considered if the active ingredient is known and disclosed.The journal publishes Special Issues in which leading experts are invited to serve as Guest Editors to compile a collection of reviews, and occasionally original articles, around a particular topical theme in neuroscience research. The list of recent Special Issues can be found here. Suggestions for Special Issues can be made directly to the Editor-in-Chief.Neuropharmacology also publishes topical narrative reviews on subjects within its remit. These reviews are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief of their intention to submit a review. Potential review authors should clearly indicate in the cover letter their expertise in the area, the timeliness of the topic, and how the review differs from, and adds to, recent published reviews on related topics. Authors are expected to have an established experimental track record in the topic of the review, and should provide full citations, including URLs/DOIs, of recent experimental papers in peer-reviewed journals relevant to the topic of the review in their cover letter. In the absence of an experimental track record, authors should provide a justification for why they believe they are the right persons to author this review article at this point in time. The absence of any such evidence of relevant experimental expertise or an explanation of author appropriateness will result in the return of the manuscript to th

From the journal's Aims & Scope

Research area (LetPub): Neurosciences

CAS Journal Ranking

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Impact

Impact factor

4.64LetPub · 2026-09-13

Impact factor (publisher)

4.7Publisher website · 2026-09-29

CiteScore 2026-06

8.1LetPub · 2026-09-13

CiteScore (publisher)

8.1Publisher website · 2026-09-29

SJR 2026-06

1.57LetPub · 2026-09-13

SNIP 2026-06

1.14LetPub · 2026-09-13

h-index

150LetPub · 2026-09-13

h-index

247OpenAlex · 2026-10-01

i10-index

11,352OpenAlex · 2026-10-01

2-year mean citedness

4.16OpenAlex · 2026-10-01

Self-citation rate

4.3%LetPub · 2026-09-13

Share of gold OA articles

30.46%LetPub · 2026-09-13

Volume

Articles per year

359LetPub · 2026-09-13

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Other sources

Average review time (community reports)

about 1 monthLetPub · 2026-09-13

Average acceptance (community reports)

75%LetPub · 2026-09-13

Submission to first decision

3 daysPublisher website · 2026-09-29

First decision after review

39 daysPublisher website · 2026-09-29

Submission to acceptance

95 daysPublisher website · 2026-09-29

Acceptance to publication

2 daysPublisher website · 2026-09-29

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Publisher

Elsevier Ltd

Country or region

ENGLAND

Language

English

Frequency

Semimonthly

Founded

1970

ISSN

0028-3908

Electronic ISSN

1873-7064

Official links

• Journal homepage ↗OpenAlex
• Submission system ↗LetPub
• Special issues ↗Publisher website